Core Viewpoint - The collaboration between Evonik and AMSilk aims to scale up the production of sustainable silk proteins, targeting high-end fashion and automotive interior markets, with a focus on biodegradable materials [3][4]. Group 1: Collaboration and Production - Evonik and AMSilk have signed a long-term agreement to enhance the sustainable silk protein production, following an initial production agreement in 2023 [3]. - A customized production line has been established at Evonik's Slovakian facility, capable of producing several tons of high-performance silk protein monthly [3]. - AMSilk will convert the silk protein powder produced by Evonik into high-performance yarn products, ensuring quality and compliance with a fully transparent European supply chain [3]. Group 2: Market Potential - The protein fiber market, which includes silk, cashmere, and merino wool, has an overall size of approximately €26 billion, with a serviceable segment of about €16 billion [4]. - The market outlook for protein fibers is positive, with increasing interest from major automotive brands like Mercedes-Benz, which has begun using silk proteins in their interior components [5]. Group 3: Financing and Expansion - AMSilk completed a €52 million financing round (approximately ¥430 million) to expand its commercial influence and support industrial scale-up to meet the growing global demand for silk protein-based biomaterials [7]. - Other companies in the protein fiber sector, such as Spiber and Solena Materials, are also making significant advancements and securing funding to enhance their production capabilities [8][12][13]. Group 4: Industry Innovations - Spiber is set to achieve an annual production capacity of 1,000 tons of its Brewed Protein™ fiber within the next few years, establishing itself as a leader in the fashion and biomaterials sectors [9][12]. - Solena Materials has announced a $6.7 million seed funding round to accelerate the large-scale production of sustainable high-performance textiles [13]. - Lingzhu Technology has successfully achieved mass production of spider silk proteins and secured significant angel funding to further its development in the bio-based materials field [14][16].

灵蛛科技的重组蛛丝蛋白纤维已获得多个品牌和机构的认可。目前，灵蛛已与多家知名企业和高校达成合作，包括： 品牌合作——灵蛛与多个国际品牌和国内头部品牌展开研发合作，共同开发基于蛛丝蛋白的创新产品，涵盖纺织品和护肤品等领域。 学术合作——灵蛛与天津工业大学、香港理工大学等高校合作，开展课题研究，进一步推动蛛丝蛋白技术的创新与应用。 灵蛛科技成立于2019年，总部位于深圳，由王博祥、梁青等人联合创立，利用微生物发酵和家蚕两条技术路径高效量产蛛丝蛋白纤维，并开发出名为"灵 丝"（LINKSilk™）的蛛丝再生纤维。王博祥博士毕业于清华大学合成生物学专业，核心团队由生物工程、材料科学及AI算法专家组成。本轮融资主要用 于产能扩张、技术研发和市场拓展。 说明：本文部分素材来自于灵蛛科技及网络公开信息，由作者重新编写，系作者个人观点，本平台发布仅为了传达一种不同观点，不代表对该观点赞同或 支持。 【生物基能源与材料】获悉，2025年5月，深圳灵蛛科技有限公司（以下简称"灵蛛科技"）宣布完成深圳市创新投资集团（简称"深创投集团"）数千万元 的天使轮融资，并成功实现重组蛛丝蛋白的量产，投产中试量产基地。这一里程碑标志着灵蛛在生 ...